Engineered immune cells may provide a novel way to protect at-risk populations from life-threatening viruses, according to a new study published on 17 May in Science Immunology. So far, the effects have only been...
Scientists have identified a type of immune cell in the lungs of humans that may help fight respiratory syncytial virus (RSV). The virus is one of the main causes of childhood hospitalisation, severe lung infection in...
Researchers at Georgia State University say a vaccine containing virus-like microscopic, genetically engineered particles — i.e.: nanoparticles, has been shown to be an effective treatment for respiratory syncytial...
Scientists at The Scripps Research Institute (TSRI) have invented a new method for designing artificial proteins, and have used it to make key ingredients for a candidate vaccine against a dangerous virus, respiratory...
A vaccine which uses ‘gold dust’ to boost the immune system has been developed by scientists. The technique sees tiny gold particles used to mimic a virus and carry proteins to immune cells in the body. Traditional...